4-73484340-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001133.2(AFM):āc.220A>Gā(p.Lys74Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,460,750 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001133.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AFM | NM_001133.2 | c.220A>G | p.Lys74Glu | missense_variant | 3/15 | ENST00000226355.5 | NP_001124.1 | |
AFM | XM_017007842.3 | c.220A>G | p.Lys74Glu | missense_variant | 3/13 | XP_016863331.1 | ||
AFM | XM_017007843.3 | c.220A>G | p.Lys74Glu | missense_variant | 3/11 | XP_016863332.1 | ||
AFM | XM_017007844.3 | c.220A>G | p.Lys74Glu | missense_variant | 3/11 | XP_016863333.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AFM | ENST00000226355.5 | c.220A>G | p.Lys74Glu | missense_variant | 3/15 | 1 | NM_001133.2 | ENSP00000226355.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1460750Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 726690
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 29, 2024 | The c.220A>G (p.K74E) alteration is located in exon 3 (coding exon 3) of the AFM gene. This alteration results from a A to G substitution at nucleotide position 220, causing the lysine (K) at amino acid position 74 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.